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Volume homeostasis, renal function and
hypertension
Jan Brod t
SUMMARY
Ageneralised vasoconstriction, foralmost a century believed to be thebasis ofall
types ofhuman hypertension, was disproved by recent haemodynamic studies.
In our investigation of hypertension in chronic parenchymatous non-uraemic,
non-anaemic renal disease, we have established that the earliest haemodynamic
abnormality in subjects, of whom over 90% later develop high blood pressure,
has actually started while their blood pressure is still normal. This consists of
hypervolaemia and a high cardiac output (hyperkinesis) with tissue hyper-
perfusion. Hypervolaemia is due to a failure ofthesestill normotensivepatients to
excrete isotonic saline as readily as subjects with completely normal kidneys.
The chronic hypervolaemia in these subjects leads to a release ofthe natriuretic
factor which depresses the Na + *K+-ATPase in the cell membranes and which is
responsible for an increase in sodium (and calcium) content of the vascular
smooth muscle cells, diminishing their compliance and thus raising the vascular
resistance together with the thickening of the vascular wall of the originally
hyperperfused vessels. With the disappearance ofthe vascularadjustment to the
increased cardiac output, the blood pressure rises and the 'pressure diuresis'
restores the circulating blood volume (and the renal homeostatic efficiency) to
normal. With a further rise of the peripheral vascular resistance the cardiac
outputfalls. At this late stage ofrenal hypertension renin mayplay a contributory
role.
Thus, the primary abnormality in the chain of events leading eventually to
hypertension is a renal inability to maintain a proper balance between sodium
intake and output. This suggested pathophysiological mechanism is probably
valid in every kind ofhuman hypertension where a reason forsuch a disturbance
is present.
INTRODUCTION
In his Legons sur les proprietes physiologiques et les alterations pathologiques
des liquides de l'organisme, published 125 years ago, Claude Bernard1 deduced
with a clear foresight that a constancy ofthe 'milieu interne' is a prerequisite ofthe
'freedom and independent existence' of the body. Fifty years later, Starling2
concluded that both the osmolality and the volume of the extracellular fluid
belong to the constants regulated by the body within narrow limits. Whilst the
former is homeostatically controlled by the hypothalmic osmoreceptors and the
posterior pituitary lobe, and whilst the organism is protected against larger losses
ofthe extracellular fluid which endanger the body by a hypovolaemicshock to the
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renin-angiotensin-aldosterone system, protection against isotonic volume
expansion appears to be less alert.
Almost 50 years ago Smith3 showed that ingestion of 1000 ml 1 % salt solution
in man will produce only a minimal (if any) diuretic response. In this respect, dogs
respond faster, the renal reaction consisting of a rise of renal blood flow and
glomerular filtration rate (GFR).4
TWOTYPESOF HAEMODYNAMIC AND DIURETIC RESPONSETO ISOTONIC
VOLUME EXPANSION IN MAN.
Studying the haemodynamic, diuretic and humoral response to an intravenous
saline infusion amounting to 2% body weight (bw), administered within 20 to 30
minutes to 61 fasting normotensive subjects recumbent at the time of the
investigation, we have observed two types of haemodynamic behaviour.5 In 31
the blood pressure remained completely unaffected by the isotonic fluid
expansion (group A), whereas in 30 the blood pressure rose by some 14 mm Hg
mean pressure (group B). Group B subjects were some 5 years older than those
in group A but there was no difference between them in weight, height or sex
distribution (Table). Group A consisted of 24 healthy subjects: four had a slight
selective proteinuria below 1 g/24 hours without any other sign of a renal
disease; in one, latent polycystic kidney disease without any restriction of renal
function was discovered in the course of family screening and two gave a history
of past border-line hypertension though blood pressure had been within the
normal range without any drugs for several months. The mean 24 h glomerular
filtration rate (GFR) of the whole group was 133 ± SEM 1 1 ml/min and the
difference between the mean GFR during day-time and night amounted to 28
+ SEM 7 ml/min. Of the 30 subjects in group B, 29 had definite signs of a renal
disease (glomerulonephritis bioptically confirmed in 13, interstitial nephropathy
in 7, polycystic kidney disease in 2, mild vascular nephrosclerosis with a normal
blood pressure at the time ofthe study in 7). Their mean GFR was also within the
normal range (126 + 1 1 ml/min), but the difference between the day-time and
nocturnal mean was reduced to 11 ± 2, 5 ml/min, which was significantly less
than in the previous group.
The cumulative water and salt excretion during the 8 hours following the infusion
amounted to 64% and 63% of the ingested load in group A and to 47% and
46% in group B (Fig 1). This points to a restriction of the volume homeostatic
70- %of theinfused water (a) ,{ 0 %ofinfused (b)
70 -%of infused
60- Na
60-
PuO.05~~~~~~~~~~~~~~~~5
40-~~~~~~~~~~~~~~~~~~5 40 A~~~~~~~~~~~~~~~~~~~~4
30-~~~~~~~~~~~~~~~~~~~4
20Contr * - Contr
20- Pat. --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pat 20
10- ~~~~~~~~~10/
1 2 3 4 5 6 7 8 h -1 2 3 4 5 6 8 h
Fig. 1. Cumulative excretion of (a) water and (b) sodium following an infusion of 20 ml/kg isotonic
saline in 20 30 minutes to 18 perfectly healthy subjects (group A, Contr.). and to 10 subjects with
minor renal pathology (group B - Pat.).
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Fig. 2. Resting circulating blood volume in
subjects of group A (normal) and group B
(normotensive renal patients) and in
hypertensive patients stage I to If WHO.
efficiency in group B with a possible
trend to volume expansion. This was
actually found.5 The circulating basic
blood volume (before the start of the
infusion) in group A was 72 ± 5 ml/kg,
and in group B 86 ± 13 ml/kg and the
difference was statistically significant
(Fig 2).
From the dilution of the plasma
proteins at the time of the infusion it
was possible to calculate that some
'AOW- cf the infiieaA lnadf uArn .tilluwinthin
the vascular bed augmenting in both groups the circulating plasma volume. In 34
subjects (13 from group A, 21 from group B) in whom we have carried out
detailed haemodynamic studies,6 7, 8 this raised the central venous pressure by
some 125% and the cardiac output (CO) bysome 25% inboth groups (Fig3).
However, in groupA there was a substantial drop of the total peripheral vascular
resistance (TPR) from a control value of 1380 dyn.cm-5 sec to less than 1000
dyn.cm-5 sec at the end of the infusion whereas its fall was irregular and much
smaller in group B. The forearm vascular resistance in group B was from the start
significantly above that of group A and the forearm venous compliance rose
markedly in group A, whilst it remained unchanged or fell in group B. Thus the
two groups differed in their reaction of the peripheral vascular bed to the volume
expansion: while it adjusted fully to the volume load in group A, it failed to adjust
in group B.
Atrial natriureticfactor. The mechanism ofthis peripheral circulatory adjustment
to the volume expansion in healthy subjects (group A) has been until recently
only partially understood. Pressure-receptors in the heart atria were suspected
andthoughtto mediate a reflex peripheral vasodilatation, slowing ofthe heart and
a slight respiratory inhibition.9' 10, 11 Recently, however, it has been possible to
extract a group of polypeptides with a strong natriuretic and vasodilating action
from the atria of rats (atrial natriuretic factor - ANF, atriopeptin). They appear to
be produced or stored in the large secretory granula of the atrial cells
(cardiocytes)12 and are released on fluid expansion into the blood leaving the
heart. Their presence has been established by radio-immunoassay, and their
diuretic action is abolished by a specific antibody.1318 No proof oftheir existence
in man has so far been reported, but, if confirmed, they would provide an
adequate explanation of the augmented vascular compliance to an increased
cardiac output and blood volume. The prompt rise of urine flow in rats contrasts
with the slow onset of the diuresis on volume expansion in man and will require
further study.
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Fig. 3. Central and peripheral haemodynamic changes after volume expansion in 13 subjects in
group A (open circles) and 21 subjects in group B (closed circles).6
Na+-K+-cell-membrane-pump inhibiting natriuretic factor. This is of a so far
uncertain biochemical nature, and is released on volume expansion from the
hypothalamus in the neighbourhood of the anterior part of the third ventricle. It
suppresses in an ouabain-like fashion the efficiency of the Na +-K+-pump in the
cell membrane of the erythrocytes, leucocytes, vascular smooth muscle, heart
muscle and possibly many other systems in the body with the result that these
cells become depleted of potassium and richer in sodium.J9-22 In the kidney this
leads to a diminished sodium reabsorption and an increased natriuresis. It has
been postulated that the diminished membrane potential permits more calcium
to enter the cells and that this is the reason for their diminished compliance,
increased contractility and irritability.23 This latter point is still controversial but
the recent findings of an increased cytoplasmic calcium in the thrombocytes of
spontaneously hypertensive rats and in essential hypertensive patients24 lend
support to this possibility.
Activation of this principle in normotensive men after volume expansion of some
3-4 litres of isotonic saline administered over several hours will lead to the
© The Ulster Medical Society, 1985.
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appearance of natriuretic activity.25,26 We have tested this question in our group
A subjects before and after volume expansion as described above, studying
the 42K-uptake from an isotonic saline solution with added 42K+ with and
without ouabain (the pump activity being the difference in 42K transport between
the two). The intra erythrocyte electrolyte concentration was also estimated.27 In
healthy subjects the 42K+ transport into the erythrocytes amounted to 1.34 ±
0.28 mmol.h-1.1-1 RBC and the intra-erythrocyte sodium concentration to
6.14 ± 1.86 mmol.l1 RBC. At the end of the infusion in these healthy subjects
the activity of the pump was unchanged (Fig 4). The meaning of this finding
will become evident after the changes in group B have been discussed. The
plasma renin activity (PRA) fell to insignificant levels after the infusion in all
lIicr-tc
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Fig. 4. Changes of plasma protein concentration,
42K-uptake by the erythrocytes and blood
pressure after volume expansion as in Fig 1 in 18
subjects of group A and 10 of group B.5
Isotonic volume expansion with a
rise of blood pressure (group B).
The situation is substantially differ-
ent in this group where the volume
expansion starts from a volume of
bloodaprioriraised. Thesepatients
had already before the beginning
of the infusion, as a consequence
of the hypervolaemia, suppressed
their Na+-K+-pump to 1.10 +
0.2 mmol K+.h-'.1-1 RBC. The
intra-erythrocyte sodium concen-
tration did not change substantially
after the 15-minute infusion, but
the intra-erythrocyte potassium
concentration was slightly reduced
in group B. These changes prob-
ably reflect an enhanced activity of
the natriuretic principle of hypo-
thalamic origin.22
Hyperkinetic circulation in the
normotensive renalpatients.
In a larger series of 97 patients (Fig
5) with chronic parenchymatous
renal disease (glomerulonephritis,
interstitial nephropathy, polycystic
kidney disease) without anaemia
(Hb above 12.5 g/dl) and with an
adequate renal function (mean 24
hr GFR over 50 ml/min), there
were 32 with a normal blood
pressure (BP= 145/95 mm Hg,
mean BP 1 15 mm Hg). More than
one-third of these had a cardiac
index exceeding by more than 2
SDO the mean of the healthy
controls (3.09 ± 0.26 I/m2/min).
In spite. of their very high cardiac
© The Ulster Medical Society, 1985.S26 The Ulster Medical Journal
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Fig. 5. Central and peripheral haemodynamic pattern, PRA and GFR in healthy controls (CON), in
normotensive renal patients (RN) and in patients with chronic non-uraemic parenchymatous renal
disease (RH -IIg, RH-ll) (WHO). The black columns indicate hyperkinetic subjects (cardiac index
above 1.d571/M2 body surface). CVP = central venous pressure.
output (the mean cardiac index of these hyperkinetic subjects amounted to 4.18
9iM2 mi) these patients remained normotensive because both their TPR and the
vascular resistance in their forearm were markedly diminished and adjusted to
their high cardiac output. This resulted in an over-perfusion of tissues, evident
from the strongly increased forearm blood flow (5 ml/100 ml forearm/min
compared with 3 ml in controls). The venous compliance was also enhanced,
adjusted for the very high circulating blood volume of 93 ml/kg. Fig 6 shows that
92% ofthese subjects developed hypertension in the course ofthe following 2 to
6 years, compared with the 45% of the normokinetic ones.8
DEVELOPMENT OF RENAL HYPERTENSION
This transition is obviously ushered in by the loss of peripheral vascular adjust-
ment: the TPR is now back at its control value, so is the forearm vascular
resistance. When this happens, the kidney is perfused under an increased
pressure, and possibly, with the contribution of the Na +-K +- inhibiting
natriuretic principle whose activity has already been raised by the hypervolaemia
of the normotensive stage (Fig 7),27 regains its volume-homeostatic efficiency at
a higher blood pressure level. This explains why in the past this 'transient variable'
of hypervolaemia, present only in the normotensive renal patients, remained
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Fig. 6. Later incidence of hypertension in
previously normotensive renal patients.
undetected, as hypertensive renal
patients were compared only with
normotensive healthy controls.28
Renin and angiotensin can hardly be
held responsible forthis loss ofperiph-
eral adjustability, PRA being the same
or even slightly lower (1.22 ng/ml/h)
in these than inthe normotensive renal
patients (1.32 ng/ml/h) where the
adjustability of the vessels had been
fullypreserved(Fig 5)8 Theoccupation
of the angiotensin vascular receptors
by the inactive angiotensin antagonist
saralasin did not reduce the blood
pressure of these early renal
hypertensive subjects (Fig 8).29
Further development of hypertension
to stage III (WHO) now becomes
entirely a function of the peripheral
Ouabain-sensitive
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Fig. 7. 42K-uptake by the erythrocytes mmol/l RBC/h and sodium content of the erythrocytes
mmol/l RBC in normotensive healthy controls (N) and in renal patients without (R- ) and with (R+)
hypertension.27
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Effect of Saralasn infusion on mean blood pressure
in renal hypertensives
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Fig. 8. Effect of a graded one hour-lasting
saralasin infusion on mean blood pressure in
chronic renal hypertensive patients. Blood
pressure fell slightly in only one subject with
severe hypertension and elevated plasma
renin activity (PRA).29
vessels whose ratio wall thickness/vessel
lumen isunchanged orraised (Fig 9)30.31
and whose compliance is diminished
(Fig 5), probably through the inhibition
of the Na + K+ pump in the smooth
vascular muscles (Fig 7). With the
increase of the TPR the cardiac output
drops back to its original volume
(reflexly?). At this late stage, we cannot
rule out the possibility that the renin
angiotensin system, whose activity is
occasionally raised, may contribute to
the development of the high TPR and of
the malignant vascular changes,32 33
accelerating from now on the downhill
course of the disease.
DISCUSSION
The message contained in these studies
can be summarised as follows. The
haemodynamic alterations leading
eventually to hypertension in chronic
non-uraemic parenchymatous renal
disease do not consist of a generalised
vasoconstriction by an overproduction
or deficiency of some vasoactive renal
agent. Instead, there is a hypervolaemia,
due-as shown by the slugcish excretion
oftheinfused saline-toadisturbed renal volume homeostasis, witha subsequent
rise in cardiac output and hyperperfusion of tissues. As long as the usual
adaptation to this occurs, no change of blood pressure will be observable.
Hypertension will develop when this peripheral adaptation is overruled -possibly
by the thickening of the previously hyperperfused vessels and by an increased
content of the smooth vascular muscles of sodium (and perhaps calcium) due to
the inhibition of the Na+-K+-pump in the vessel wall by the ouabain-like
natriuretic factorreleased bythe initial hypervolaemia ofthechronicrenal disease.
A few critical words about the methods on which these important conclusions are
based must be added. The cardiac output is the mean of at least three successive
measurements at 5 to 10 minute intervals under resting conditions, and the
difference between the individual data did not exceed 10%. The intra-individual
confidence interval between single readings amounted to 8.3% . The error
involved in the measurement of the circulating blood volume by the dilution of
the 113indium-labelled transferrin on repeated measurements in the same person
was + 5% and the values agree with those obtained with the 5ICr-labelled
erythrocytes. Uncertainty exists aboutthe best reference basis. Whilst our isotope
laboratory uses body weight for this purpose, it appears that body height may be
more suitable.28 We have therefore related our data to both the weight and body
surface, the calculation of which includes both these parameters. The results with
both these methods revealed the same significant difference between blood
volume of the renal hyperkinetic normotensives and all the other subgroups. The
slightly higher age (5 years) of group B can hardly be held responsible for a 20%
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Fig. 9. The ratio 'maximum hyperaemic' to resting forearm blood flow, forearm vascular resistance
and plasma renin activity (PRA). A vessel can dilate on the removal of all vasoconstrictor influences
only to a given maximum. Hence a constricted vessel will dilate on producing maximum hyperaemia
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difference in the cardiac output between groups A and B. We thus could see no
other reason why the hypervolaemia and hyperkinesis should be restricted to the
normotensive renal patients than that these two changes are the first steps in the
development of the haemodynamic abnormality of chronic renal disease leading
eventually to hypertension, being analogous to the changes produced by isotonic
volume expansion in normotensive subjects with a slight renal defect.
Whereas in healthy normotensive subjects on mild to moderate volume
expansion a mechanism analogous to the ANF in rats produces increasing
vascular compliance and urine flow, a larger fluid expansion, or a fluid expansion
superimposed on a volume of blood a priori raised, as in normotensive subjects
with a renal defect, will activate the Na+-K+-pump inhibiting factor. Whether
by this time the vasodilating activity is already exhausted by the protracted
hypervolaemia, as suggested by the depletion of the secretory granules in the
cardiocytes on volume expansion in rats,34 or whether in the competition ofthese
two activities (which obviously differ in the mechanism of their action), the
ouabain-like factor gains the upper hand, is a matter for further study. Perhaps
the sodium- and calcium-loaded vascular smooth muscle cells cannot respond
any more to the vasodilating principle.
Thewaysbywhich renal disease interfereswith thevolume homeostatic efficiency
of the kidney have still to be explored. Although the GFR of many of the
investigated patients was within the normal range, the day and night span of the
GFR was reduced in group B, suggesting that the adaptation ofthis renal function
to the exigencies of the volume homeostasis may be restricted. Knowledge ofthe
effect of the various renal parenchymatous diseases on the various intrarenal
natriuretic humoral factors, such as the prostaglandins, dopamine35 or kallikrein,
is inadequate. On the other hand it is certain that many other conditions causing
hypertension, such as primary aldosteronism (Conn's syndrome), renal artery
stenosis or constriction, and intrarenal vasoconstriction, interfere with normal
sodium excretion and thus with volume homeostasis.
In essential hypertension there are several possibilities, corresponding perhaps to
different etiologies of the disease. There are many indications that the autonomic
equilibrium is out of balance, with a 'sympathetic overdrive' starting when the
subject was no more than 20 to 30 years of age.36 40 The consequence is an
exaggerated reaction to simple blood pressure-raising stimuli (pain, rage, anxiety)
which in the kidney leads to a protracted exaggerated vasoconstriction. The
previous reaction may actually merge with the next one and eventually may be
present for most of the day, leading to positive water and salt balance. As the
sympathetic overactivity may stop during quiet night sleep, the renal vaso-
constriction will subside explaining the nocturia of these early essential hyper-
tensives, present in some 60% of cases.41,42 There are also age-dependent
changes in the kidneys which may be the basis of the blood pressure rise with
age,43 such as the progressive thickening of the glomerular basement membrane
with age in rats.44 Whether this has an analogy in man is so far unknown. The
genetic element may have something to do with the renal natriuretic cascade
which is still a wide field for investigation.
Thus even a slight restriction of renal function may reduce volume homeostatic
efficiency and raise blood pressure. This will re-establish volume homeostasis at
a higher blood pressure level. However, the organism has to pay a high price for
this compensation by an increased risk of cardiovascular complications which
may prove fatal.
© The Ulster Medical Society, 1985.
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APPENDIX
Methods used
Blood pressure
Cardiac output
strain gauge, catheter in the femoral artery.
Indocyanine green dilution, arterial blood drawn from
femoral artery.
Total peripheral
vascular
resistance (TPR)
mean BP (electronically integrated)
cardiac output/60
< 1332 dyn.cm-5 sec.
Forearm blood
flow
Forearm vascular
resist.
Forearm blood
volume
Venous
distensibility
(compliance)
Central venous
pressure
Plasma renin
activity (PRA)
Glomerular
filtration rate
(GFR)
Whitney occlusion plethysmograph.
mean blood pressure
x 1332 x 10-5
forearm blood flow/60
113indium-transferrin dilution in the forearm
1/2 hour after its injection by a central catheter
is quantitatively calibrated by the increase
in both volume (AV) (measured A A A
plethysmographically) and radioactivity (A A): = -
AV V
Forearm blood volume/forearm venous pressure
Catheter in superior vena cava close to the atrium.
Isotope double dilution technique.
Mean of the endogenous creatinine clearance for two
12-hour periods.
This paper is dedicated to the memory of my friend Mr Max Freeland, to whose great organisational
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and to Miss Maria Futterova who was an excellent technical assistant.
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